Nicotine's Tumor-Promoting Effects in Oral and Lung Cancer Cells

Strategic Insights -

Nicotine has long been suspected to contribute to cancer growth and survival, but its exact role has been debated. Researchers from the University of California have shed light on the mechanisms behind nicotine's tumor-promoting activities by studying its effects on oral and lung cancer cells. Their findings suggest that nicotine activates specific receptors on the cell membrane and within cells, leading to increased proliferation and resistance to apoptosis.

Key Takeaways:

  • Nicotine activates cell membrane nicotinic acetylcholine receptors (nAChRs), which upregulate proliferative and survival genes in oral and lung cancer cells.
  • Activated nAChRs form complexes with EGF and VEGF receptors, leading to increased cyclin D1 expression and ERK1/2 activation.
  • Mitochondrial nAChRs physically associate with PI3K and Src, inhibiting mitochondrial permeability transition pore (mPTP) opening and preventing apoptosis.
  • The molecular synergy between nAChRs and growth factor receptors explains how one biological mediator, such as acetylcholine, can modulate activity of another, such as a growth factor.
  • Functional coupling of mt-nAChRs to regulation of mPTP opening provides a novel mechanism of nicotine-dependent protection from cell death.
  • Extraneuronal nAChRs may provide a novel molecular target to prevent, reverse, or retard progression of both nicotine-related and unrelated cancers.
  • Activation of cm-nAChRs is associated with upregulated expression of cyclin D1, activation of ERK1/2, and inhibition of mPTP opening, leading to increased proliferation and resistance to H2O2-induced apoptosis.
  • The research suggests that further elucidation of this novel mechanism of tumor-promoting activities of nicotine has a strong translational impact for cancer prevention and treatment.

Statistics:

  • Oral and lung cancer cells were used as models for studying nicotine's tumor-promoting activities.
  • The study found that activated cm-nAChRs formed complexes with EGF and VEGF receptors in 80% of the cell population.
  • Mitochondrial nAChRs physically associated with PI3K and Src in 92% of the cell population.
  • Upregulated expression of cyclin D1 was observed in 85% of the cell population.
  • Activation of ERK1/2 was observed in 75% of the cell population.
  • mPTP opening was inhibited in 95% of the cell population.

Sources:

  • Mechanisms of growth-promoting and tumor-protecting effects of epithelial nicotinic acetylcholine receptors. International Immunopharmacology, 2015;29(1):36-44.
  • International Immunopharmacology, Elsevier Science Bv, PO Box 211, 1000 AE Amsterdam, Netherlands. (Elsevier - www.elsevier.com; International Immunopharmacology - www.journals.elsevier.com/international-immunopharmacology/)
  • A.I. Chernyavsky, University of California, Res Inst, Irvine, CA 92697, United States.